TransCode TherapeuticsRNAZ 
$3.85-1.79%24h
-1.79%24h
Global rank20273
Market cap$96.63M
Change 7d-47.97%
YTD Performance-40.22%
SP500 benchmarkUnderperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Category
Market capitalization of TransCode Therapeutics (RNAZ)
As of December 2024, TransCode Therapeutics has a market cap of $96.63M. This makes TransCode Therapeutics the world's 20273th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Market cap history of TransCode Therapeutics from 2021 to 2024
-
Value:-
Market cap history of TransCode Therapeutics from 2021 to 2024
| Year | Market Cap | Change |
|---|---|---|
| 2024 | $16.86M | -89.81% |
| 2023 | $165.44M | -98.78% |
| 2022 | $13.51B | -73.50% |
| 2021 | $51.00B | - |
RNAZ Market Cap Today is $96.63M -1.79% - 21 Dec 2024
View largest stocks by market cap 
